Annet G H Roodvoets
Overview
Explore the profile of Annet G H Roodvoets including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
775
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Geubels B, van den Esschert A, Temmink S, Nilsson P, Martling A, Roodvoets A, et al.
Br J Surg
. 2024 Oct;
111(10.
PMID: 39392106
No abstract available.
2.
Zwart W, Temmink S, Hospers G, Marijnen C, Putter H, Nagtegaal I, et al.
Eur J Cancer
. 2024 Apr;
204:114044.
PMID: 38636289
Background: A pathological complete response (pCR) following chemoradiation (CRT) or short-course radiotherapy (scRT) leads to a favourable prognosis in patients with rectal cancer. Total neo-adjuvant therapy (TNT) doubles the pCR...
3.
Prata I, Eriksson M, Krdzalic J, Meershoek-Klein Kranenbarg E, Roodvoets A, Beets-Tan R, et al.
Insights Imaging
. 2023 Nov;
14(1):206.
PMID: 38001376
Background: Magnetic resonance (MR) imaging is the modality used for baseline assessment of locally advanced rectal cancer (LARC) and restaging after neoadjuvant treatment. The overall audited quality of MR imaging...
4.
Nilsson P, van Etten B, Hospers G, Marijnen C, Meershoek-Klein Kranenberg E, Roodvoets A, et al.
Dis Colon Rectum
. 2023 Oct;
67(2):e126.
PMID: 37889954
No abstract available.
5.
Fernandez L, Sao Juliao G, Renehan A, Beets G, Papoila A, Vailati B, et al.
Dis Colon Rectum
. 2023 Jul;
66(10):e1054-e1055.
PMID: 37493212
No abstract available.
6.
Bahadoer R, Hospers G, Marijnen C, Peeters K, Putter H, Dijkstra E, et al.
Eur J Cancer
. 2023 Mar;
185:139-149.
PMID: 36996624
Introduction: Although optimising rectal cancer treatment has reduced local recurrence rates, many patients develop distant metastases (DM). The current study investigated whether a total neoadjuvant treatment strategy influences the development,...
7.
Temmink S, Peeters K, Bahadoer R, Meershoek-Klein Kranenbarg E, Roodvoets A, Melenhorst J, et al.
Br J Surg
. 2023 Mar;
110(6):676-684.
PMID: 36972213
Background: In rectal cancer, watch and wait for patients with a cCR after neoadjuvant treatment has an established evidence base. However, there is a lack of consensus on the definition...
8.
Dijkstra E, Nilsson P, Hospers G, Bahadoer R, Meershoek-Klein Kranenbarg E, Roodvoets A, et al.
Ann Surg
. 2023 Jan;
278(4):e766-e772.
PMID: 36661037
Objective: To analyze risk and patterns of locoregional failure (LRF) in patients of the RAPIDO trial at 5 years. Background: Multimodality treatment improves local control in rectal cancer. Total neoadjuvant...
9.
Fernandez L, Sao Juliao G, Renehan A, Beets G, Papoila A, Vailati B, et al.
Dis Colon Rectum
. 2022 Dec;
66(1):41-49.
PMID: 36515514
Background: Nearly 30% of patients with rectal cancer develop local regrowth after initial clinical complete response managed by watch and wait. These patients might be at higher risk for distant...
10.
Dijkstra E, Hospers G, Meershoek-Klein Kranenbarg E, Fleer J, Roodvoets A, Bahadoer R, et al.
Radiother Oncol
. 2022 Apr;
171:69-76.
PMID: 35447283
Background And Purpose: The RAPIDO trial demonstrated a decrease in disease-related treatment failure (DrTF) and an increase in pathological complete responses (pCR) in locally advanced rectal cancer (LARC) patients receiving...